3Scan – 2018 Year in Review December 18, 2018


3Scan – 2018 Year in Review    December 18, 2018

A Murine Brain Reconstruction in 3D for The Future is Now exhibition, Victoria & Albert Museum in London

transformative year for our company

For 3Scan, 2018 has been a busy year. We grew to 40 full time employees including adding Steve England as our first ever Chief Science Officer. In June we launched our first “off the shelf” product – the 3Scan Vascular Fingerprint™ assay as a beta program. We made news with grants, awards and new collaborations. Through it all we stayed true to our mission of revolutionizing the way tissue is examined to empower the next generation of medical discovery. Please take a few minutes to review some of our recent efforts through the articles and links below.

3Scan Vascular Fingerprint™ Assay

This year saw the release of our first product offering the 3Scan Vascular Fingerprint™. After diligently gathering customer requirements in the field of vascular biology exploration, we carefully crafted a product that not only offers comprehensive imagery of a particular tissue sample, but quantification (vessel diameter, count, and density). Over fifty vascular researchers from around the world have already signed up to participate in our beta program.

3Scan in Print and Press

Our strategy for this year was to get the word out about the benefits of leveraging 3Scan technology and expertise to enable Discovery in 3D. Through a combination of partnerships, presentations, and press releases our technology was viewed more that 500,000,000 times. Below are just a few of the topics that 3Scan made buzz worthy in 2018.
As this year comes to a close, we want to thank you for being part of this amazing year. We look forward to working together in 2019!
© 3Scan  2122 Bryant Street, San Francisco, California 94110    info@3Scan.com